Intracranial Arteriovenous Malformation
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
Schizophrenia
|
0.500 |
Biomarker
|
disease |
PSYGENET |
β2 microglobulin, HLA-A and Notch4 were all expressed in a pattern where inflammatory illness was associated with increased expression in controls but not in subjects with schizophrenia.
|
23395714 |
2013 |
leukemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
654P/int3- enh/3'-enh vector containing transgenes such as suicide genes might become useful tools for leukemia-specific gene therapy.
|
14737070 |
2004 |
Childhood Leukemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
654P/int3- enh/3'-enh vector containing transgenes such as suicide genes might become useful tools for leukemia-specific gene therapy.
|
14737070 |
2004 |
Ameloblastoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Ameloblastoma tumor epithelium demonstrated positive expression for Notch1 (n = 5/10), Notch3 (n = 8/10), Notch4 (n = 10/10), Jagged1 (n = 6/10) and Delta1 (n = 5/10), but no reactivity for Notch2 (n = 10/10) and Jagged2 (10/10).
|
20337864 |
2010 |
Hepatitis B
|
0.010 |
Biomarker
|
disease |
BEFREE |
Hepatitis B virus X protein activates Notch signaling by its effects on Notch1 and Notch4 in human hepatocellular carcinoma.
|
26530164 |
2016 |
Alopecia
|
0.020 |
Biomarker
|
disease |
BEFREE |
Notch4, a non-HLA gene in the MHC is strongly associated with the most severe form of alopecia areata.
|
12589427 |
2003 |
Alopecia Areata
|
0.020 |
Biomarker
|
disease |
BEFREE |
Notch4, a non-HLA gene in the MHC is strongly associated with the most severe form of alopecia areata.
|
12589427 |
2003 |
Schizophrenia
|
0.500 |
Biomarker
|
disease |
BEFREE |
NOTCH4 is not a significant susceptibility gene for schizophrenia when clinical heterogeneity is ignored; however, NOTCH4 may be associated with early-onset schizophrenia or schizophrenia with many negative symptoms, but these findings should be interpreted cautiously.
|
12873802 |
2003 |
Hypertriglyceridemia
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
Int3/3'-ass/C(-6) --> T was found in both groups in the present study although it was regarded as a pathogenic variant to HTG earlier on.
|
17560523 |
2007 |
Adenoid Cystic Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Notch-4 contributes to the metastasis of salivary adenoid cystic carcinoma.
|
20596622 |
2010 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
NOTCH4 inhibition reduced tumour volume and tumourigenicity of mouse xenografts.
|
24403446 |
2014 |
Triple Negative Breast Neoplasms
|
0.050 |
Biomarker
|
disease |
BEFREE |
NOTCH4 is a new potential therapeutic target for triple-negative breast cancer.
|
24403446 |
2014 |
Triple-Negative Breast Carcinoma
|
0.040 |
Biomarker
|
disease |
BEFREE |
NOTCH4 is a new potential therapeutic target for triple-negative breast cancer.
|
24403446 |
2014 |
Treatment-resistant schizophrenia
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
NOTCH4 rs367398 was not statistically significantly associated with the occurrence of treatment-resistant schizophrenia after the correction for multiple testing.
|
25529856 |
2015 |
Treatment-resistant schizophrenia
|
0.310 |
Biomarker
|
disease |
PSYGENET |
NOTCH4 rs367398 was not statistically significantly associated with the occurrence of treatment-resistant schizophrenia after the correction for multiple testing.
|
25529856 |
2015 |
Malignant neoplasm of breast
|
0.400 |
Biomarker
|
disease |
BEFREE |
Notch4 Signaling Confers Susceptibility to TRAIL-Induced Apoptosis in Breast Cancer Cells.
|
25704336 |
2015 |
Breast Carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Notch4 Signaling Confers Susceptibility to TRAIL-Induced Apoptosis in Breast Cancer Cells.
|
25704336 |
2015 |
ovarian neoplasm
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Notch4 mRNA high expression was not found to be significantly correlated to OS for all ovarian cancer patients, serous cancer patients, and endometrioid cancer patients.
|
26662955 |
2016 |
Malignant neoplasm of ovary
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Notch4 mRNA high expression was not found to be significantly correlated to OS for all ovarian cancer patients, serous cancer patients, and endometrioid cancer patients.
|
26662955 |
2016 |
Carcinoma, Ovarian Epithelial
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Notch4 mRNA high expression was not found to be significantly correlated to OS for all ovarian cancer patients, serous cancer patients, and endometrioid cancer patients.
|
26662955 |
2016 |
Arteriovenous hemangioma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
NOTCH4 gene polymorphisms as potential risk factors for brain arteriovenous malformation development and hemorrhagic presentation.
|
27231971 |
2017 |
Tumor Cell Invasion
|
0.050 |
AlteredExpression
|
phenotype |
BEFREE |
Notch-4 silencing also resulted in decreased cell migration and invasion and affected the expression of EMT markers.
|
28374086 |
2017 |
ovarian neoplasm
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Notch4 mRNA high expression was significantly correlated with favorite OS, but not PFS and PPS for all ovarian cancer patients.
|
28415574 |
2017 |
Malignant neoplasm of ovary
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Notch4 mRNA high expression was significantly correlated with favorite OS, but not PFS and PPS for all ovarian cancer patients.
|
28415574 |
2017 |